Form 4: Procter & Gamble Director Acquires 175 Shares of Common Stock

Director Christopher J. Kempczinski acquired 175 shares of Procter & Gamble common stock on December 10, 2024, through a grant of restricted stock units.

Summary

• Christopher J. Kempczinski, a director at Procter & Gamble, acquired 175 shares of common stock on December 10, 2024.
• The acquisition was made through a grant of restricted stock units under the company's 2019 Stock and Incentive Compensation Plan.
• The price per share for the acquisition was $0, as it was a grant of restricted stock units.
• Following the transaction, Mr. Kempczinski beneficially owns 8,469.7188 shares of Procter & Gamble common stock, which includes dividend equivalents in the form of restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally neutral to positive. The acquisition of shares by a director can be seen as a positive sign of confidence in the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to stock-based compensation for a company director, which is common practice in publicly traded companies.

Comparison to Industry Standards

• Stock grants to directors are a common practice across publicly traded companies as part of their compensation packages.
• The number of shares granted is relatively small compared to the overall outstanding shares of Procter & Gamble, which is typical for director grants.
• Companies like Unilever, Colgate-Palmolive, and Kimberly-Clark also use stock-based compensation for their directors, with similar reporting requirements.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.

Key Dates

Keywords

Procter & Gamble, Director, Stock Acquisition, Restricted Stock Units, Beneficial Ownership, SEC Form 4, PG